Clinical Trial Update: Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating camrelizumab in combination with AVD as first-line therapy for patients with advanced classical Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING